Trials / Recruiting
RecruitingNCT05234177
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
Tempus CRC Surveillance Study: A Longitudinal Circulating Tumor DNA (ctDNA) Biomarker Profiling Study of Patients With Colorectal Cancer (CRC) Using Comprehensive Next-Generation Sequencing (NGS)Assays
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- Tempus AI · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study is an observational multicenter evaluation of participants with colorectal cancer (CRC) who will receive longitudinal plasma ctDNA biomarker profiling in addition to their standard-of-care therapy and disease surveillance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Observation | No intervention |
Timeline
- Start date
- 2022-06-21
- Primary completion
- 2027-02-01
- Completion
- 2029-02-01
- First posted
- 2022-02-10
- Last updated
- 2025-05-06
Locations
20 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT05234177. Inclusion in this directory is not an endorsement.